Have a personal or library account? Click to login
Drug- and Toxin-Induced Opsoclonus – a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy Cover

Drug- and Toxin-Induced Opsoclonus – a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy

Tremor and Other Hyperkinetic Movements
Volume 14 (2024): Issue 1
By: Hugo Cannilla,  Maria Messe,  François Girardin,  François-Xavier Borruat and  Julien F. Bally  
Open Access
|May 2024

References

  1. 1Leigh RJ, Zee DS. The neurology of eye movements. 5th edition. Oxford; New York: Oxford University Press; 2015. 1109 p. (Contemporary neurology series). DOI: 10.1093/med/9780199969289.001.0001
    Back to article
  2. 2Grossman SN, Rucker JC. Opsoclonus and ocular flutter: evaluation and management. Curr Opin Ophthalmol. 2023 Nov; 34(6): 465–9. DOI: 10.1097/ICU.0000000000000998
    Back to article
  3. 3Margolin E, Jeeva-Patel T. Opsoclonus. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023 [cited 2023 Jun 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK564353/.
    Back to article
  4. 4Bellur SN. Opsoclonus: Its clinical value. Neurology. 1975 Jun; 25(6): 502–7. DOI: 10.1212/WNL.25.6.502
    Back to article
  5. 5Wong A. An update on opsoclonus. Curr Opin Neurol. 2007; 20(1): 25–31. DOI: 10.1097/WCO.0b013e3280126b51
    Back to article
  6. 6Averbuch-Heller L, Remler B. Opsoclonus. Semin Neurol. 1996 Mar; 16(01): 21–6. DOI: 10.1055/s-2008-1040955
    Back to article
  7. 7Eurípedes Marchiori P, Mies S, Scaff M. Cyclosporine A-induced ocular opsoclonus and reversible leukoencephalopathy after orthotopic liver transplantation: Brief report. Clin Neuropharmacol. 2004; 27(4): 195–7. DOI: 10.1097/01.wnf.0000134409.97397.5e
    Back to article
  8. 8Wong AMF, Musallam S, Tomlinson RD, Shannon P, Sharpe JA. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci. 2001 Aug; 189(1–2): 71–81. DOI: 10.1016/S0022-510X(01)00564-0
    Back to article
  9. 9Shameer Nijam M, Thambirajah N, Vithanawasam D, Vithanage K, Liyanage D, Gooneratne I, et al. Phencyclidine: A rare cause of saccadic intrusions. Ann Indian Acad Neurol. 2019; 22(4): 503–5. DOI: 10.4103/aian.AIAN_174_18
    Back to article
  10. 10Oh SY, Kim JS, Dieterich M. Update on opsoclonus–myoclonus syndrome in adults. J Neurol. 2019; 266(6): 1541–8. DOI: 10.1007/s00415-018-9138-7
    Back to article
  11. 11Blumkin L, Kivity S, Lev D, Cohen S, Shomrat R, Lerman-Sagie T, et al. A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J Neurol. 2012; 259(12): 2590–8. DOI: 10.1007/s00415-012-6545-z
    Back to article
  12. 12Blain PG, Nightingale S, Stoddart JC. Strychnine Poisoning: Abnormal Eye Movements. J Toxicol Clin Toxicol. 1982 Jan; 19(2): 215–7. DOI: 10.3109/15563658208990383
    Back to article
  13. 13Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug; 30(2): 239–45. DOI: 10.1038/clpt.1981.154
    Back to article
  14. 14Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord. 2022 Jun; 37(6): 1131–48. DOI: 10.1002/mds.29005
    Back to article
  15. 15O’Connor A, Ruha AM. Clinical course of bark scorpion envenomation managed without antivenom. J Med Toxicol Off J Am Coll Med Toxicol. 2012 Sep; 8(3): 258–62. DOI: 10.1007/s13181-012-0233-3
    Back to article
  16. 16O’Connor AD, Padilla-Jones A, Ruha AM. Severe bark scorpion envenomation in adults*. Clin Toxicol. 2018; 56(3): 170–4. DOI: 10.1080/15563650.2017.1353095
    Back to article
  17. 17Martinez AJ, Taylor JR, Dyck PJ, Houff SA, Isaacs E. Chlordecone intoxication in man. II. Ultrastructure of peripheral nerves and skeletal muscle. Neurology. 1978 Jul; 28(7): 631–5. DOI: 10.1212/WNL.28.7.631
    Back to article
  18. 18Cannon SB, Veazey JMJ, Jackson RS, Burse VW, Hayes C, Straub WE, et al. Epidemic kepone poisoning in chemical workers. Am J Epidemiol. 1978 Jun; 107(6): 529–37. DOI: 10.1093/oxfordjournals.aje.a112572
    Back to article
  19. 19Taylor JR. Neurological manifestations in humans exposed to chlordecone and follow-up results. Neurotoxicology. 1982 Oct; 3(2): 9–16.
    Back to article
  20. 20Taylor JR. Neurological manifestations in humans exposed to chlordecone: follow-up results. Neurotoxicology. 1985 Spring; 6(1): 231–6.
    Back to article
  21. 21Chlordecone fiche 3 [Internet]. Available from: https://www.atctoxicologie.fr/images/FTEC/chlordecone__fiche_3.pdf.
    Back to article
  22. 22Brumlik J, Means ED. TREMORINE-TREMOR, SHIVERING AND ACUTE CEREBELLAR ATAXIA IN THE ADULT AND CHILD—A COMPARATIVE STUDY. Brain. 1969; 92(1): 157–90. DOI: 10.1093/brain/92.1.157
    Back to article
  23. 23Irioka T, Yamanami A, Uchida N, Iwase M, Yasuhara H, Mizusawa H. Opsoclonus caused by diphenhydramine self-poisoning. United States: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2009 Mar; 72–3. DOI: 10.1097/WNO.0b013e318197f6ff
    Back to article
  24. 24Hermann DM, Bassetti CL. Reversible opsoclonus after diphenhydramine misuse. Eur Neurol. 2005; 53(1): 46–7. DOI: 10.1159/000084266
    Back to article
  25. 25Carstairs SD, Schneir AB. Opsoclonus Due to Diphenhydramine Poisoning. N Engl J Med. 2010 Dec 30; 363(27): e40. DOI: 10.1056/NEJMicm1002035
    Back to article
  26. 26Rajasekharan C, Renjith SW, Jayapal T. Opsoclonus and lingual myoclonus due to organophosphate poisoning: images in clinical medicine. Case Rep. 2012 Sep 21. DOI: 10.1136/bcr-2012-007043
    Back to article
  27. 27Pullicino P, Aquilina J. Opsoclonus in organophosphate poisoning. Arch Neurol. 1989; 46(6): 704–5. DOI: 10.1001/archneur.1989.00520420126037
    Back to article
  28. 28De Bleecker JL. Transient opsoclonus in organophosphate poisoning. Acta Neurol Scand. 1992 Nov; 86(5): 529–31. DOI: 10.1111/j.1600-0404.1992.tb05138.x
    Back to article
  29. 29Organophosphates (NIH) [Internet]. [cited 2023 May 16]. Available from: https://web.archive.org/web/20170424180321/https://tools.niehs.nih.gov/srp/research/research4_s3_s5.cfm.
    Back to article
  30. 30Dorandeu F, Dhote F, Calas G, Nachon F. Les oximes dans le traitement des intoxications aiguës par organophosphorés : est-il raisonnable de vouloir s’en passer? Toxicol Anal Clin. 2014 Dec; 26(4): 218. DOI: 10.1016/j.toxac.2014.09.020
    Back to article
  31. 31Opsoclonus and lingual myoclonus due to organophosphate poisoning: images in clinical medicine. Vol. 2012. 2012. DOI: 10.1136/bcr-2012-007043
    Back to article
  32. 32Thome-Souza S, Moreira B, Valente KD. Late adverse effects of the coadministration of valproate and lamotrigine. Pediatr Neurol. 2012; 47(1): 47–50. DOI: 10.1016/j.pediatrneurol.2012.04.026
    Back to article
  33. 33Dehaene I, Van Vleymen B. Opsoclonus induced by phenytoin and diazepam. 1987 Feb p. 216. United States: Annals of neurology. DOI: 10.1002/ana.410210220
    Back to article
  34. 34Verma R, Kumar S, Biyani S, Singh A. Opsoclonus - Myoclonus syndrome induced by phenytoin intoxication. J Neurosci Rural Pract. 2014; 5(5): S109–10. DOI: 10.4103/0976-3147.145254
    Back to article
  35. 35Nelson JL, Blume GM, Bansal SK, Kaufman JR, Woods FR, Zhang X, et al. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc. 2022; 42(2): 251–5. DOI: 10.1097/WNO.0000000000001498
    Back to article
  36. 36Elkardoudi-Pijnenburg Y, Van Vliet AG. Opsoclonus, a rare complication of cocaine misuse. Journal of neurology, neurosurgery, and psychiatry. 1996 May; 592. DOI: 10.1136/jnnp.60.5.592
    Back to article
  37. 37Scharf D. Opsoclonus-myoclonus following the intranasal usage of cocaine. J Neurol Neurosurg Psychiatry. 1989; 52(12): 1447–8. DOI: 10.1136/jnnp.52.12.1447-a
    Back to article
  38. 38Kang HG, Park SK, Wang SJ, Oh SY, Ryu HU. Opsoclonus-myoclonus syndrome following long-term use of cyclosporine. Clin Toxicol. 2018; 56(5): 373–6. DOI: 10.1080/15563650.2017.1375511
    Back to article
  39. 39Porges Y, Blumen S, Fireman Z, Sternberg A, Zamir D. Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn disease. Am J Ophthalmol. 1998 Oct; 126(4): 607–9. DOI: 10.1016/S0002-9394(98)00137-8
    Back to article
  40. 40Apsner R, Schulenburg A, Steinhoff N, Keil F, Janata K, Kalhs P, et al. Cyclosporin A-induced ocular flutter after marrow transplantation. Bone Marrow Transplant. 1997 Aug 1; 20(3): 255–6. DOI: 10.1038/sj.bmt.1700809
    Back to article
  41. 41Lazar RB, Ho SU, Melen O, Daghestani AN. Multifocal central nervous system damage caused by toluene abuse. Neurology. 1983 Oct; 33(10): 1337–40. DOI: 10.1212/WNL.33.10.1337
    Back to article
  42. 42Papageorgiou SG, Karantoni E, Pandis D, Kouzoupis AV, Kalfakis N, Limouris GS. Severe dopaminergic pathways damage in a case of chronic toluene abuse. Clin Neurol Neurosurg. 2009 Dec; 111(10): 864–7. DOI: 10.1016/j.clineuro.2009.07.007
    Back to article
  43. 43Toluene [Internet]. Available from: https://www.ilo.org/dyn/icsc/showcard.display?p_lang=fr&p_card_id=0078.
    Back to article
  44. 44Toluene toxicity. Available from: http://flipper.diff.org/app/items/info/5367.
    Back to article
  45. 45Cohen WJ, Cohen NH. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA. 1974 Dec 2; 230(9): 1283–7. DOI: 10.1001/jama.230.9.1283
    Back to article
  46. 46Haloperidol [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/3559.
    Back to article
  47. 47Lee E, Williams Z, Goodman C, Oriaku E, Harris C, Thomas M, et al. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells. NeuroToxicology. 2006 Jul; 27(4): 558–66. DOI: 10.1016/j.neuro.2006.02.006
    Back to article
  48. 48Takahata R, Moghaddam B. Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine. Neuropsychopharmacology. 2003 Jun; 28(6): 1117–24. DOI: 10.1038/sj.npp.1300127
    Back to article
  49. 49Glover RL, Connors NJ, Stefan C, Wong E, Hoffman RS, Nelson LS, et al. Electromyographic and laboratory findings in acute Solanum torvum poisoning. Clin Toxicol Phila Pa. 2016; 54(1): 61–5. DOI: 10.3109/15563650.2015.1110749
    Back to article
  50. 50Smith SW, Giesbrecht E, Thompson M, Nelson LS, Hoffman RS. Solanaceous steroidal glycoalkaloids and poisoning by Solanum torvum, the normally edible susumber berry. Toxicon. 2008 Nov; 52(6): 667–76. DOI: 10.1016/j.toxicon.2008.07.016
    Back to article
  51. 51Antezana A, Policard J, Sarva H, Vas G. Susumber berries: Unexpected cause of cholinergic poisoning. Neurol Clin Pract. 2012 Dec 1; 2(4): 362–3. DOI: 10.1212/CPJ.0b013e31826af1f6
    Back to article
  52. 52Osorio-Rico L, Santamaria A, Galván-Arzate S. Thallium Toxicity: General Issues, Neurological Symptoms, and Neurotoxic Mechanisms. In: Aschner M, Costa LG, (eds.), Neurotoxicity of Metals [Internet]. Cham: Springer International Publishing; 2017 [cited 2023 Jun 29]. pp. 345–53. (Advances in Neurobiology; vol. 18). Available from: http://link.springer.com/10.1007/978-3-319-60189-2_17. DOI: 10.1007/978-3-319-60189-2_17
    Back to article
  53. 53Thallium [Internet]. Available from: https://www.sciencedirect.com/journal/electroencephalography-and-clinical-neurophysiology/vol/38/issue/1.
    Back to article
  54. 54Lizarraga KJ, Heros DO, Adams D, Lang AE, Kanner AM. Opsoclonus-myoclonus-encephalopathy induced by cefepime. J Neurol Sci. 2019; 396 ((Lizarraga K.J., karlo.lizarraga@gmail.com; Heros D.O.; Adams D.; Kanner A.M.) Department of Neurology, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL, United States): 33–5. DOI: 10.1016/j.jns.2018.10.028
    Back to article
  55. 55Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, et al. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017 Dec; 21(1): 276. DOI: 10.1186/s13054-017-1856-1
    Back to article
  56. 56Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013 Dec; 17(6): R264. DOI: 10.1186/cc13094
    Back to article
  57. 57Rudolph S, Perakis A, Gizzi M. Ocular Flutter in Vidarabine Toxicity. Am J Ophthalmol. 1990 Jan; 109(1): 105. DOI: 10.1016/S0002-9394(14)75598-9
    Back to article
  58. 58Player B, Harmelink M, Bordini B, Weisgerber M, Girolami M, Croix M. Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome Associated With Anti-N-methyl-D-aspartate Receptor Encephalitis. Pediatr Neurol. 2015 Nov; 53(5): 456–8. DOI: 10.1016/j.pediatrneurol.2015.07.010
    Back to article
  59. 59Smith JH. N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus: Treatment Response to Plasmapheresis. Arch Neurol. 2011 Aug 1; 68(8): 1069. DOI: 10.1001/archneurol.2011.166
    Back to article
  60. 60Armangue T, Titulaer MJ, Sabater L, Pardo-Moreno J, Gresa-Arribas N, Barbero-Bordallo N, et al. A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol. 2014 Mar; 75(3): 435–41. DOI: 10.1002/ana.23917
    Back to article
  61. 61Lee JY, Kwon E, Kim HJ, Choi JY, Oh HJ, Kim JS. Opsoclonus Following Downbeat Nystagmus in Absence of Visual Fixation in Multiple System Atrophy: Modulation and Mechanisms. Cerebellum Lond Engl. 2021 Oct; 20(5): 724–33. DOI: 10.1007/s12311-019-01090-w
    Back to article
  62. 62Shindo K, Onohara A, Hata T, Kobayashi F, Nagasaka K, Nagasaka T, et al. Opsoclonus-myoclonus syndrome associated with multiple system atrophy. Cerebellum Ataxias. 2014; 1: 15. DOI: 10.1186/s40673-014-0015-6
    Back to article
  63. 63Maramattom BV, Lotlikar RS, Sukumaran S. Central nervous system adverse events after ChAdOx1 vaccination. Neurol Sci. 2022; 43(6): 3503–7. DOI: 10.1007/s10072-022-06000-3
    Back to article
  64. 64Lai YH, Chen LW, Hsueh YY. Delayed neurological sequelae in an infant after carbon monoxide intoxication. J Burn Care Res. 2021; 42(5): 1035–7. DOI: 10.1093/jbcr/irab074
    Back to article
  65. 65Au WJ, Keltner JL. Opsoclonus with amitriptyline overdose. Ann Neurol. 1979; 6(1): 87. DOI: 10.1002/ana.410060128
    Back to article
  66. 66Necpál J, Skorvanek M. Opsoclonus-myoclonus ataxia syndrome secondary to venlafaxine intoxication. J. Neurosci. 2016; 372: 19–20. DOI: 10.1016/j.jns.2016.11.023
    Back to article
DOI: https://doi.org/10.5334/tohm.832 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 24, 2023
Accepted on: Mar 21, 2024
Published on: May 8, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Opsoclonus,
Opsoclonus-Myoclonus Syndrome,
Drug-induced,
Multiple system atrophy,
Drug Adverse effects

© 2024 Hugo Cannilla, Maria Messe, François Girardin, François-Xavier Borruat, Julien F. Bally, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 14 (2024): Issue 1Next article